[1] Coakley AJ, Kettle AG, Wells CP, et al. 99Tcm sestamibi—a new agent for parathyroid imaging[J]. Nucl Med Commun, 1989, 10(11):791-794.  doi: 10.1097/00006231-198911000-00003
[2] Taillefer R, Boucher Y, Potvin C, et al. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi(double-phase study)[J]. J Nucl Med, 1992, 33(10):1801-1807.
[3] Kannan S, Milas M, Neumann D, et al. Parathyroid nuclear scan. A focused review on the technical and biological factors affecting its outcome[J]. Clin Cases Miner Bone Metab, 2014, 11(1):25-30.
[4] Isik S, Akbaba G, Berker D, et al. Thyroid-related factors that influence preoperative localization of parathyroid adenomas[J]. Endocr Pract, 2012, 18(1):26-33.
[5]

Tunninen V, Varjo P, Schildt J, et al. Comparison of five parathyroid scintigraphic protocols[J/OL]. Int J Mol Imaging, 2013, 2013[2014-11-14]. http://www. hindawi. com/journals/ijmi/2013/921260.

[6] Keane DF, Roberts G, Smith R, et al. Planar parathyroid localization scintigraphy:a comparison of subtraction and 1-, 2- and 3-h washout protocols[J]. Nucl Med Commun, 2013, 34(6):582-589.
[7] Burke JF, Naraharisetty K, Schneider DF, et al. Early-phase technetium-99m sestamibi scintigraphy can improve preoperative localization in primary hyperparathyroidism[J]. Am J Surg, 2013, 205(3):269-273.  doi: 10.1016/j.amjsurg.2013.01.001
[8] Moriyama T, Kageyama K, Nigawara T, et al. Diagnosis of a case of ectopic parathyroid adenoma on the early image of 99mTc-MIBI scintigram[J]. Endocr J, 2007, 54(3):437-440.
[9] Martínez-Rodríguez I, Banzo I, Quirce R, et al. Early planar and early SPECT Tc-99m sestamibi imaging:can it replace the dual-phase technique for the localization of parathyroid adenomas by omitting the delayed phase?[J]. Clin Nucl Med, 2011, 36(9):749-753.  doi: 10.1097/RLU.0b013e318217568a
[10] Yang J, Hao R, Yuan L, et al. Value of dual-phase 99mTc-sestamibi scintigraphy with neck and thoracic SPECT/CT in secondary hyperparathyroidism[J]. AJR Am J Roentgenol, 2014, 202(1):180-184.  doi: 10.2214/AJR.13.11053
[11] Fuster D, Depetris M, Torregrosa JV, et al. Advantages of pinhole collimator double-phase scintigraphy with 99mTc-MIBI in secondary hyperparathyroidism[J]. Clin Nucl Med, 2013, 38(11):878-881.  doi: 10.1097/RLU.0b013e3182a77d0d
[12] Wachtel H, Bartlett EK, Kelz RR, et al. Primary hyperparathyroidism with negative imaging:a significant clinical problem[J]. Ann Surg, 2014, 260(3):474-480.  doi: 10.1097/SLA.0000000000000875
[13] Hassler S, Ben-Sellem D, Hubele F, et al. Dual-isotope 99mTc-MIBI/123I parathyroid scintigraphy in primary hyperparathyroidism:comparison of subtraction SPECT/CT and pinhole planar scan[J]. Clin Nucl Med, 2014, 39(1):32-36.
[14] Vitetta GM, Neri P, Chiecchio A, et al. Role of ultrasonography in the management of patients with primary hyperparathyroidism:retrospective comparison with technetium-99m sestamibi scintigraphy[J]. J Ultrasound, 2014, 17(1):1-12.  doi: 10.1007/s40477-014-0067-8
[15] Noda S, Onoda N, Kashiwagi S, et al. Strategy of operative treatment of hyperparathyroidism using US scan and 99mTc-MIBI SPECT/CT[J]. Endocr J, 2014, 61(3):225-230.
[16] Zhen L, Li H, Liu X, et al. The application of SPECT/CT for preoperative planning in patients with secondary hyperparathyroidism[J]. Nucl Med Commun, 2013, 34(5):439-444.
[17] Smith RB, Evasovich M, Girod DA, et al. Ultrasound for localization in primary hyperparathyroidism[J]. Otolaryngol Head Neck Surg, 2013, 149(3):366-371.
[18] Michel L, Dupont M, Rosiere A, et al. The rationale for performing MR imaging before surgery for primary hyperparathyroidism[J]. Acta Chir Belg, 2013, 113(2):112-122.  doi: 10.1080/00015458.2013.11680896
[19] Kwon JH, Kim EK, Lee HS, et al. Neck ultrasonography as preoperative localization of primary hyperparathyroidism with an additional role of detecting thyroid malignancy[J]. Eur J Radiol, 2013, 82(1):e17-21.
[20] Kim YI, Jung YH, Hwang KT, et al. Efficacy of 99mTc-sestamibi SPECT/CT for minimally invasive parathyroidectomy:comparative study with 99mTc-sestamibi scintigraphy, SPECT, US and CT[J]. Ann Nucl Med, 2012, 26(10):804-810.  doi: 10.1007/s12149-012-0641-0
[21] Akbaba G, Berker D, Isik S, et al. A comparative study of pre-operative imaging methods in patients with primary hyperparathyroidism:ultrasonography, 99mTc sestamibi, single photon emission computed tomography, and magnetic resonance imaging[J]. J Endocrinol Invest, 2012, 35(4):359-364.
[22] Cheung K, Wang TS, Farrokhyar F, et al. A meta-analysis of preoperative localization techniques for patients with primary hyperparathyroidism[J]. Ann Surg Oncol, 2012, 19(2):577-583.  doi: 10.1245/s10434-011-1870-5
[23] Untch BR, Adam MA, Scheri RP, et al. Surgeon-performed ultrasound is superior to 99Tc-sestamibi scanning to localize parathyroid adenomas in patients with primary hyperparathyroidism:results in 516 patients over 10 years[J]. J Am Coll Surg, 2011, 212(4):522-529.  doi: 10.1016/j.jamcollsurg.2010.12.038
[24] Oksüz MO, Dittmann H, Wicke C, et al. Accuracy of parathyroid imaging:a comparison of planar scintigraphy, SPECT, SPECT-CT, and C-11 methionine PET for the detection of parathyroid adenomas and glandular hyperplasia[J]. Diagn Interv Radiol, 2011, 17(4):297-307.
[25] Leupe PK, Delaere PR, Vander Poorten VL, et al. Pre-operative imaging in primary hyperparathyroidism with ultrasonography and sestamibi scintigraphy[J]. B-Ent, 2011, 7(3):173-180.
[26] Wimmer G, Profanter C, Kovacs P, et al. CT-MIBI-SPECT image fusion predicts multiglandular disease in hyperparathyroidism[J]. Langenbecks Arch Surg, 2010, 395(1):73-80.  doi: 10.1007/s00423-009-0545-1
[27] Vulpio C, Bossola M, De Gaetano A, et al. Usefulness of the combination of ultrasonography and 99mTc-sestamibi scintigraphy in the preoperative evaluation of uremic secondary hyperparathyroidism[J]. Head Neck, 2010, 32(9):1226-1235.  doi: 10.1002/hed.21320
[28] Pata G, Casella C, Besuzio S, et al. Clinical appraisal of 99mtechnetium-sestamibi SPECT/CT compared to conventional SPECT in patients with primary hyperparathyroidism and concomitant nodular goiter[J]. Thyroid, 2010, 20(10):1121-1127.  doi: 10.1089/thy.2010.0035
[29] Patel CN, Salahudeen HM, Lansdown M, et al. Clinical utility of ultrasound and 99mTc sestamibi SPECT/CT for preoperative localization of parathyroid adenoma in patients with primary hyperparathyroidism[J]. Clin Radiol, 2010, 65(4):278-287.
[30] García-Talavera P, González ML, Aís G, et al. SPECT-CT in the localization of an ectopic retropharyngeal parathyroid adenoma as a cause for persistent primary hyperparathyroidism[J]. Rev Esp Med Nucl Imagen Mol, 2012, 31(5):275-277.
[31] Serra A, Bolasco P, Satta L, et al. Role of SPECT/CT in the preoperative assessment of hyperparathyroid patients[J]. Radiol Med, 2006, 111(7):999-1008.
[32] Taieb D, Hindie E, Grassetto G, et al. Parathyroid scintigraphy:when, how, and why? A concise systematic review[J]. Clin Nucl Med, 2012, 37(6):568-574.
[33] Qiu ZL, Wu CG, Zhu RS, et al. Unusual case of solitary functioning bone metastasis from a "parathyroid adenoma":imagiologic diagnosis and treatment with percutaneous vertebroplasty—case report and literature review[J]. J Clin Endocrinol Metab, 2013, 98(9):3555-3561.
[34] Bural GG, Muthukrishnan A, Oborski MJ, et al. Improved benefit of SPECT/CT compared to SPECT alone for the accurate localization of endocrine and neuroendocrine tumors[J]. Mol Imaging Radionucl Ther, 2012, 21(3):91-96.
[35] Dasgupta DJ, Navalkissoor S, Ganatra RA. The role of single-photon emission computed tomography/computed tomography in localizing parathyroid adenoma[J]. Nucl Med Commun, 2013, 34(7):621-626.
[36] Sager S, Shafipour H, Asa S, et al. Comparison of Tc-99m pertechnetate images with dual-phase Tc 99m MIBI and SPECT images in primary hyperparathyroidism[J]. Indian J Endocrinol Metab, 2014, 18(4):531-536.  doi: 10.4103/2230-8210.137520
[37] Gotway MB, Reddy GP, Webb WR, et al. Comparison between MR imaging and 99mTc MIBI scintigraphy in the evaluation of recurrent of persistent hyperparathyroidism[J]. Radiology, 2001, 218(3):783-790.
[38] Ernst O. Hyperparathyroidism:CT and MR findings[J]. J Radiol, 2009, 90(3 Pt 2):409-412.
[39] Saengsuda Y. The accuracy of 99mTc-MIBI scintigraphy for preoperative parathyroid localization in primary and secondary-tertiary hyperparathyroidism[J]. J Med Assoc Thai, 2012, 95(Suppl 3):S81-91.
[40] Caldarella C, Treglia G, Pontecorvi A, et al. Diagnostic performance of planar scintigraphy using 99mTc-MIBI in patients with secondary hyperparathyroidism:a meta-analysis[J]. Ann Nucl Med, 2012, 26(10):794-803.  doi: 10.1007/s12149-012-0643-y
[41] Dotzenrath C, Cupisti K, Goretzki E, et al. Operative treatment of renal autonomous hyperparathyroidism:cause of persistent or recurrent disease in 304 patients[J]. Langenbecks Arch Surg, 2003, 387(9/10):348-354.
[42] Chroustova D, Kubinyi J, Trnka J, et al. The role of 99mTc-MIBI SPECT/low dose CT with 3D subtraction in patients with secondary hyperparathyroidism due to chronic kidney disease[J]. Endocr Regul, 2014, 48(2):55-63.
[43] Hindie E, Ugur O, Fuster D, et al. 2009 EANM parathyroid guidelines[J]. Eur J Nucl Med Mol Imaging, 2009, 36(7):1201-1216.  doi: 10.1007/s00259-009-1131-z
[44] Phitayakorn R, Mchenry CR. Incidence and location of ectopic abnormal parathyroid glands[J]. Am J Surg, 2006, 191(3):418-423.  doi: 10.1016/j.amjsurg.2005.10.049
[45] Andrade JS, Mangussi-Gomes JP, Rocha LA, et al. Localization of ectopic and supernumerary parathyroid glands in patients with secondary and tertiary hyperparathyroidism:surgical description and correlation with preoperative ultrasonography and Tc99m-Sestamibi scintigraphy[J]. Braz J Otorhinolaryngol, 2014, 80(1):29-34.  doi: 10.5935/1808-8694.20140008
[46] Kaushal DK, Mishra A, Mittal N, et al. Successful removal of intrathyroidal parathyroid adenoma diagnosed and accurately located preoperatively by parathyroid scintigraphy(SPECT-CT)[J]. Indian J Nucl Med, 2010, 25(2):62-63.  doi: 10.4103/0972-3919.72689
[47] Shafiei B, Hoseinzadeh S, Fotouhi F, et al. Preoperative 99mTc-sestamibi scintigraphy in patients with primary hyperparathyroidism and concomitant nodular goiter:comparison of SPECT-CT, SPECT, and planar imaging[J]. Nucl Med Commun, 2012, 33(10):1070-1076.  doi: 10.1097/MNM.0b013e32835710b6
[48] Im HJ, Lee IK, Paeng JC, et al. Functional evaluation of parathyroid adenoma using 99mTc-MIBI parathyroid SPECT/CT:correlation with functional markers and disease severity[J]. Nucl Med Commun, 2014, 35(6):649-654.
[49] Cheon M, Choi JY, Chung JH, et al. Differential findings of tc-99m sestamibi dual-phase parathyroid scintigraphy between benign and malignant parathyroid lesions in patients with primary hyperparathyroidism[J]. Nucl Med Mol Imaging, 2011, 45(4):276-284.
[50] Mshelia DS, Hatutale AN, Mokgoro NP, et al. Correlation between serum Calcium levels and dual-phase 99mTc-sestamibi parathyroid scintigraphy in primary hyperparathyroidism[J]. Clin Physiol Funct Imaging, 2012, 32(1):19-24.  doi: 10.1111/j.1475-097X.2011.01048.x
[51] Qiu ZL, Wu B, Shen CT, et al. Dual-phase 99mTc-MIBI scintigraphy with delayed neck and thorax SPECT/CT and bone scintigraphy in patients with primary hyperparathyroidism:correlation with clinical or pathological variables[J]. Ann Nucl Med, 2014, 28(8):725-735.  doi: 10.1007/s12149-014-0876-z
[52] Hughes DT, Sorensen MJ, Miller BS, et al. The biochemical severity of primary hyperparathyroidism correlates with the localization accuracy of sestamibi and surgeon-performed ultrasound[J]. J Am Coll Surg, 2014, 219(5):1010-1019.  doi: 10.1016/j.jamcollsurg.2014.06.020
[53] Hoda NE, Phillips P, Ahmed N. Recommendations after non-localizing sestamibi and ultrasound scans in primary hyperparathyroid disease:order more scans or explore surgically?[J]. J Miss State Med Assoc, 2013, 54(2):36-41.
[54] Alabed YZ, Rakheja R, Novales-Diaz JA. Recurrent parathyroid carcinoma appearing as FDG negative but MIBI positive[J]. Clin Nucl Med, 2014, 39(7):e362-364.
[55] Traub-Weidinger T, Mayerhoefer ME, Koperek O, et al. 11C-Methionine PET/CT imaging of 99mTc-MIBI-SPECT/CT negative patients with primary hyperparathyroidism and previous neck surgery[J]. J Clin Endocrinol Metab, 2014, 99(11):4199-4205.  doi: 10.1210/jc.2014-1267
[56] Caldarella C, Treglia G, Isgrò MA, et al. Diagnostic performance of positron emission tomography using 11C-methionine in patients with suspected parathyroid adenoma:a meta-analysis[J]. Endocrine, 2013, 43(1):78-83.
[57] Hayakawa N, Nakamoto Y, Kurihara K, et al. A comparison between 11C-methionine PET/CT and MIBI SPECT/CT for localization of parathyroid adenomas/hyperplasia[J]. Nucl Med Commun, 2015, 36(1):53-59.
[58] Lezaic L, Rep S, Sever MJ, et al. 18F-Fluorocholine PET/CT for localization of hyperfunctioning parathyroid tissue in primary hyperparathyroidism:a pilot study[J]. Eur J Nucl Med Mol Imaging, 2014, 41(11):2083-2089.  doi: 10.1007/s00259-014-2837-0
[59] Kelly HR. Hamberg LM, Hunter GJ. 4D-CT for preoperative localization of abnormal parathyroid glands in patients with hyperparathyroidism:accuracy and ability to stratify patients by unilateral versus bilateral disease in surgery-naive and re-exploration patients[J]. AJNR Am J Neuroradiol, 2014, 35(1):176-181.  doi: 10.3174/ajnr.A3615
[60] Kukar M, Platz TA, Schaffner TJ, et al. The Use of modified Four-Dimensional Computed Tomography in Patients with Primary Hyperparathyroidism:An Argument for the Abandonment of Routine Sestamibi Single-Positron Emission Computed Tomography(SPECT)[J]. Ann Surg Oncol, 2015, 22(1):139-145.  doi: 10.1245/s10434-014-3940-y
[61] Popowicz B, Klencki M, Sporny S, et al. Usefulness of PTH measurements in FNAB washouts in the identification of pathological parathyroids—analysis of the factors that influence the effectiveness of this method[J]. Endokrynol Pol, 2014, 65(1):25-32.  doi: 10.5603/EP.2014.0004
[62] Van Hoorn RA, Vriens D, Postema J, et al. The influence of SPECT Reconstruction algorithms on image quality and diagnostic accuracy in phantom measurements and 99mTc-sestamibi parathyroid scintigraphy[J]. Nucl Med Commun, 2014, 35(1):64-72.
[63] Livingston CD. Radioguided parathyroidectomy is successful in 98.7% of selected patients[J]. Endocr Pract, 2014, 20(4):305-309.
[64] Onoda N, Ishikawa T, Nishiyama NA, et al. Focused approach to ectopic mediastinal parathyroid surgery assisted by radio-guided navigation[J]. Surg Today, 2014, 44(3):533-539.
[65] Linhartová M, MitášL, StarýK, et al. The value of intraoperative ultrasonography in parathyroid surgery[J]. Rozhl Chir, 2012, 91(11):614-619.
[66] van der Vorst JR, Schaafsma BE, Verbeek FP, et al. Intraoperative near-infrared fluorescence imaging of parathyroid adenomas with use of low-dose methylene blue[J]. Head Neck, 2014, 36(6):853-858.